EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Infection of Rhesus Macaques with O’nyong-nyong virus UVRI-0804 recapitulates key aspects of human clinical disease

Hannah K Jaeger, Michael Denton, Takeshi F Andoh, Craig N Kreklywich, Lina Gao, Lydia J Pung, Zachary J Streblow, Ann McMonigal, Karina Ray, Brayden Graves, Magdalene M Streblow, Aaron M Barber-Axthelm und 10 weitere

PLOS Neglected Tropical Diseases · 10.07.2026 · 20 (7) · e0013780

DOI: 10.1371/journal.pntd.0013780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 10.07.2026. Verfasst von Hannah K Jaeger und 21 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America. Hauptthemen laut MEDLINE: Disease Models, Animal, O'nyong-nyong Virus, Alphavirus Infections. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, Foundation for the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

O’nyong-nyong virus (ONNV) is a mosquito-borne alphavirus first isolated in Uganda in 1959. Since its discovery, ONNV has caused several outbreaks in Africa, manifesting clinically as fever, rash, and joint/muscle pain lasting months. Currently, we have a limited understanding of ONNV infection and disease in relevant animal models, which restricts the evaluation of vaccines and therapeutics. In 1967, Binn et al. reported that infection of rhesus macaques (RMs) with ONNV failed to induce viremia in two animals. This may be attributed to the potential attenuation of the virus through extensive passaging. To mitigate this issue, we constructed an infectious clone from the sequence of ONNV-UVRI0804 (ONNV 0804 ), a 2017 clinical isolate from a febrile patient in Uganda. This strain demonstrated high pathogenicity in immunocompetent mice, resulting in an earlier and more severe onset of disease and significantly higher viremia compared to a highly passaged control strain ONNV UgMP30 . In the current study, three male and three female rhesus macaques were subcutaneously inoculated with ONNV 0804 . All animals became viremic at 2 days post inoculation (dpi). Both classical and nonclassical monocytes were activated (CD169+), peaking at 3 dpi, which corresponded with the peak of plasma viral RNA. Additionally, CD4+ and CD8 + effector memory T cells and memory B cells began proliferating in peripheral blood by day 7, peaking at day 10, which also corresponded to the timing of neutralizing antibody development, indicating a robust adaptive immune response to ONNV 0804 . Finally, key clinical disease manifestations were recapitulated, including lymphadenopathy and histological features of early-stage arthritis. Taken together, rhesus macaque infection with ONNV 0804 clinical isolate is a promising model for investigating immune responses to alphaviruses and evaluating vaccines to protect against future epidemics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease Models, AnimalO'nyong-nyong VirusAlphavirus InfectionsAnimalsMacaca mulattaHumansFemaleAntibodies, ViralViremiaMaleCD8-Positive T-LymphocytesAntibodies, Neutralizing

Substanzen

Antibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.
  • Bioinformatics & Biostatistics Core, Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
  • Biostatistics Shared Resources, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
  • Division of Pathobiology & Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
  • Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
  • Department of Biochemistry & Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

ORCID-Profile: Daniel N Streblow

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • Foundation for the National Institutes of Health

Zitieren

APA

Jaeger, H. K., Denton, M., Andoh, T. F., Kreklywich, C. N., Gao, L., Pung, L. J., Streblow, Z. J., McMonigal, A., Ray, K., Graves, B., Streblow, M. M., Barber-Axthelm, A. M., Zilverberg, G., Terry, M., Fei, S. S., Hogan, G., Schultz, D. C., Cherry, S., Axthelm, M. K., …, & Streblow, D. N. (2026). Infection of Rhesus Macaques with O’nyong-nyong virus UVRI-0804 recapitulates key aspects of human clinical disease. PLOS Neglected Tropical Diseases, 20(7), e0013780. https://doi.org/10.1371/journal.pntd.0013780

Vancouver

Jaeger HK, Denton M, Andoh TF, Kreklywich CN, Gao L, Pung LJ, et al. Infection of Rhesus Macaques with O’nyong-nyong virus UVRI-0804 recapitulates key aspects of human clinical disease. PLOS Neglected Tropical Diseases. 2026;20(7):e0013780. doi:10.1371/journal.pntd.0013780

BibTeX
@article{Jaeger2026,
  author = {Jaeger, Hannah K and Denton, Michael and Andoh, Takeshi F and Kreklywich, Craig N and Gao, Lina and Pung, Lydia J and Streblow, Zachary J and McMonigal, Ann and Ray, Karina and Graves, Brayden and Streblow, Magdalene M and Barber-Axthelm, Aaron M and Zilverberg, Gavin and Terry, Margaret and Fei, Suzanne S and Hogan, Glenn and Schultz, David C and Cherry, Sara and Axthelm, Michael K and Labriola, Caralyn S and Heise, Mark T and Streblow, Daniel N},
  title = {Infection of Rhesus Macaques with O’nyong-nyong virus UVRI-0804 recapitulates key aspects of human clinical disease},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2026},
  volume = {20},
  number = {7},
  pages = {e0013780},
  doi = {10.1371/journal.pntd.0013780}
}
Kostenlos starten →